Pantothenic Acid for Health & Longevity

Created on 11/06/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Pantothenic acid (vitamin B5) is an essential vitamin cells need to turn food into energy, sold as a supplement taken in high doses for clearer skin and healthy aging. Ordinary diets almost always supply enough. For adults who eat well, the case for taking more is weak: the strongest signals are small and indirect. Nutritional doses are low-risk; high-dose use for longevity remains unproven, with real uncertainty in both directions. (Full Review)

Protocol

Nutritional baseline (Institute of Medicine panel)
5 mg/day
Adequate intake for adults; 6 mg/day in pregnancy, 7 mg/day in lactation; no safety data exist for high doses in pregnancy or lactation
High-dose skin approach (popularized by Lit-Hung Leung)
2.2 g/day
The only acne trial used two doses with food for 12 weeks
Pantethine lipid approach (Japanese and Italian practice)
300 mg three times daily
Or 600 mg/day for 8 weeks then 900 mg/day; this is pantethine, not pantothenic acid
Time to effect
Correction of pantothenic acid deficiency
Weeks
Deficiency symptoms resolve
Acne lesion reduction
12 weeks
Assessment point of the acne trial
LDL cholesterol lowering (pantethine)
8 weeks
Effect held through week 16

Benefits

Contraindications
  • People with known hypersensitivity to pantothenic acid, calcium pantothenate or dexpanthenol
  • People with a prior eosinophilic reaction to pantothenic acid or biotin
Key Interactions
  • Calcium hopantenate: linked to fatal Reye-like encephalopathy in older patients
  • Cardiac glycosides (digoxin): possible change in effect, unquantified
Theoretical (inferred from mechanism)
  • High-dose biotin: may reduce biotin absorption
  • Tetracycline and fluoroquinolone antibiotics, thyroid hormone and bisphosphonates (doxycycline, levothyroxine): reduced drug absorption
  • Lipid-lowering agents (atorvastatin, red yeast rice) with pantethine: additive LDL lowering
  • Cholinesterase inhibitors (donepezil, rivastigmine): additive cholinergic effects (nausea, slow heart rate)
  • Immune checkpoint inhibitors (nivolumab, pembrolizumab): possible altered efficacy or immune side effects
  • Other interventions: topical dexpanthenol products add allergen exposure in people prone to contact dermatitis

Risk & Side Effects

  • High:
  • Medium:
  • Low: Gastrointestinal upset at gram doses; eosinophilic pleuropericarditis; liver enzyme elevation with megavitamin combinations; allergic contact dermatitis from topical dexpanthenol
  • Speculative: Reduced biotin uptake at high doses

Monitoring

Marker Target Why
24-hour urinary pantothenic acid No established target; track change from own baseline Reflects recent intake
Whole-blood pantothenic acid 1.57–2.66 µmol/L Status marker
LDL cholesterol (pantethine users) No established target for this use; track change from own baseline Expected to change with pantethine
Apolipoprotein B (apoB) Not specified in the ER LDL carrier protein; paired with LDL cholesterol
Eosinophil count 0–500 cells/µL Safety check: rise stops use
ALT and AST ALT about 7–56 U/L; AST about 10–40 U/L Safety check: rise stops megavitamin use

Cadence: Baseline before gram-level pantothenic acid or pantethine: complete blood count with differential, liver enzymes and, when lipids are the goal, a fasting lipid panel. Repeat lipid panel at 8 and 16 weeks for pantethine; liver enzymes at 6–8 weeks, then every 6–12 months for multi-gram vitamin combinations; blood count whenever chest pain, breathlessness or rash appears. Nutritional doses of 5–10 mg/day need no testing.

Qualitative Assessment

  • Acne lesion count and skin clarity, using standardized photographs at baseline and week 12
  • Gastrointestinal comfort, including stool frequency and any diarrhea at gram doses
  • New skin rash, chest discomfort or breathlessness as early warning signs
  • Energy levels and fatigue, recognizing that change is unlikely in replete adults